These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 29132396)

  • 21. Utility of circulating tumor cells and DNA in the management of advanced colorectal cancer.
    Pan X; Zhang X
    Future Oncol; 2020 Jun; 16(18):1289-1299. PubMed ID: 32379501
    [No Abstract]   [Full Text] [Related]  

  • 22. [Circulating tumor cells (CTCs)--clinical significance in patients with ovarian cancer].
    Magnowski P; Bochyński H; Nowak-Markwitz E; Zabel M; Spaczyński M
    Ginekol Pol; 2012 Apr; 83(4):291-4. PubMed ID: 22712262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
    Zhang X; Ju S; Wang X; Cong H
    Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.
    Venesio T; Siravegna G; Bardelli A; Sapino A
    Pathobiology; 2018; 85(1-2):146-154. PubMed ID: 28614831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid Biopsy, the hype vs. hope in molecular and clinical oncology.
    Mohanty A; Mohanty SK; Rout S; Pani C
    Semin Oncol; 2021 Jun; 48(3):259-267. PubMed ID: 34384614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid biopsy: paving a new avenue for cancer research.
    Kurma K; Eslami-S Z; Alix-Panabières C; Cayrefourcq L
    Cell Adh Migr; 2024 Dec; 18(1):1-26. PubMed ID: 39219215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
    Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
    Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid biopsies.
    Lianidou E; Pantel K
    Genes Chromosomes Cancer; 2019 Apr; 58(4):219-232. PubMed ID: 30382599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
    Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
    Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Significance of Circulating Tumour Cells in the Clinic.
    Abalde-Cela S; Piairo P; Diéguez L
    Acta Cytol; 2019; 63(6):466-478. PubMed ID: 30820013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Liquid Biopsy in Monitoring Colorectal Cancer Progression Shows Strong Clinical Correlation.
    Sun Q; Liu Y; Liu B; Liu Y
    Am J Med Sci; 2018 Mar; 355(3):220-227. PubMed ID: 29549923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
    Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
    Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic potential of mutation detection from single circulating tumor cells in cancer patients.
    Salvianti F; Pinzani P
    Expert Rev Mol Diagn; 2017 Nov; 17(11):975-981. PubMed ID: 28931314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer.
    Abreu M; Cabezas-Sainz P; Alonso-Alconada L; Ferreirós A; Mondelo-Macía P; Lago-Lestón RM; Abalo A; Díaz E; Palacios-Zambrano S; Rojo-Sebastian A; López-López R; Sánchez L; Moreno-Bueno G; Muinelo-Romay L
    Cells; 2020 May; 9(5):. PubMed ID: 32423054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
    Ignatiadis M; Lee M; Jeffrey SS
    Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.